These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33294493)

  • 1. CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain.
    Mathiesen SN; Lock JL; Schoderboeck L; Abraham WC; Hughes SM
    Mol Ther Methods Clin Dev; 2020 Dec; 19():447-458. PubMed ID: 33294493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice.
    Xie BS; Wang X; Pan YH; Jiang G; Feng JF; Lin Y
    Theranostics; 2021; 11(3):1177-1191. PubMed ID: 33391529
    [No Abstract]   [Full Text] [Related]  

  • 3. Pilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques.
    Arotcarena ML; Dovero S; Biendon N; Dutheil N; Planche V; Bezard E; Dehay B
    Front Bioeng Biotechnol; 2021; 9():762209. PubMed ID: 34869273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
    Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
    Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9.
    Chatterjee D; Marmion DJ; McBride JL; Manfredsson FP; Butler D; Messer A; Kordower JH
    Gene Ther; 2022 Jun; 29(6):390-397. PubMed ID: 33753910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.B.
    Dayton RD; Grames MS; Klein RL
    Gene Ther; 2018 Aug; 25(5):392-400. PubMed ID: 30013186
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Batista AR; King OD; Reardon CP; Davis C; Shankaracharya ; Philip V; Gray-Edwards H; Aronin N; Lutz C; Landers J; Sena-Esteves M
    Hum Gene Ther; 2020 Jan; 31(1-2):90-102. PubMed ID: 31696742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
    Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
    Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
    Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
    Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PhP.B Enhanced Adeno-Associated Virus Mediated-Expression Following Systemic Delivery or Direct Brain Administration.
    Pietersz KL; Plessis FD; Pouw SM; Liefhebber JM; van Deventer SJ; Martens GJM; Konstantinova PS; Blits B
    Front Bioeng Biotechnol; 2021; 9():679483. PubMed ID: 34414171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice.
    Torregrosa T; Lehman S; Hana S; Marsh G; Xu S; Koszka K; Mastrangelo N; McCampbell A; Henderson CE; Lo SC
    Gene Ther; 2021 Aug; 28(7-8):456-468. PubMed ID: 33612827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient whole brain transduction by systemic infusion of minimally purified AAV-PHP.eB.
    Konno A; Hirai H
    J Neurosci Methods; 2020 Dec; 346():108914. PubMed ID: 32810474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient retinal ganglion cells transduction by retro-orbital venous sinus injection of AAV-PHP.eB in mature mice.
    Tang M; Zhong L; Rong H; Li K; Ye M; Peng J; Ge J
    Exp Eye Res; 2024 Jul; 244():109931. PubMed ID: 38763353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NeuroD1 Regulated Endothelial Gene Expression to Modulate Transduction of AAV-PHP.eB and Recovery Progress after Ischemic Stroke.
    He X; Wang X; Wang H; Wang T; Yang F; Chen Y; Pei Z; Bai Y; Li W; Wu Z; Chen G
    Aging Dis; 2023 Dec; 15(6):2632-2649. PubMed ID: 38270116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of receptor usage by the engineered capsid AAV-PHP.eB.
    Jang S; Shen HK; Ding X; Miles TF; Gradinaru V
    Mol Ther Methods Clin Dev; 2022 Sep; 26():343-354. PubMed ID: 36034770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of CNS tropic AAV1-like variants with reduced liver-targeting following systemic administration in mice.
    Drouyer M; Merjane J; Nazareth D; Knight M; Scott S; Liao SHY; Ginn SL; Zhu E; Alexander IE; Lisowski L
    Mol Ther; 2024 Mar; 32(3):818-836. PubMed ID: 38297833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids.
    Huang Q; Chan KY; Tobey IG; Chan YA; Poterba T; Boutros CL; Balazs AB; Daneman R; Bloom JM; Seed C; Deverman BE
    PLoS One; 2019; 14(11):e0225206. PubMed ID: 31725765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV-PHP.eB transduces both the inner and outer retina with high efficacy in mice.
    Palfi A; Chadderton N; Millington-Ward S; Post I; Humphries P; Kenna PF; Farrar GJ
    Mol Ther Methods Clin Dev; 2022 Jun; 25():236-249. PubMed ID: 35474956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B.
    Jackson KL; Dayton RD; Deverman BE; Klein RL
    Front Mol Neurosci; 2016; 9():116. PubMed ID: 27867348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Customized blood-brain barrier shuttle peptide to increase AAV9 vector crossing the BBB and augment transduction in the brain.
    Zhang X; Chai Z; Lee Dobbins A; Itano MS; Askew C; Miao Z; Niu H; Samulski RJ; Li C
    Biomaterials; 2022 Feb; 281():121340. PubMed ID: 34998171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.